Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Macaulay

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Value in Health Regional Issues|November 25, 2016
Registration and Reimbursement of New Cancer Medicines in Australia-Response to Letter to the Editor by Michael WonderRichard Macaulay
Expert Review of Pharmacoeconomics & Outcomes Research|May 13, 2021
Accounting for inflation within NICE cost-effectiveness thresholdsVincent Low, Richard Macaulay
Value in Health Regional Issues|April 27, 2018
How Data Packages Lacking Phase III Pivotal Trial Data Can Support Regulatory Approval and Reimbursement for Oncologics in AustraliaRichard Macaulay, Mohammad Kashif Siddiqui, Samuel Stoddart
Age (Dordrecht, Netherlands)|January 19, 2012
The role of the T cell in age-related inflammationRichard Macaulay, Arne N Akbar, Sian M Henson
Immunology|January 4, 2012
Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockadeSian M Henson, Richard Macaulay, Ornella Franzese, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 3, 2019
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspectiveRichard Macaulay, Amit Ahuja, Ebenezer Ademisoye, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
The Role of Noncomparative Evidence in Health Technology Assessment DecisionsElizabeth A Griffiths, Richard Macaulay, Nirma K Vadlamudi, et al.
Human Immunology|December 11, 2012
Differing HLA types influence inhibitory receptor signalling in CMV-specific CD8+ T cellsRichard Macaulay, Natalie E Riddell, Stephen J Griffiths, et al.
European Journal of Immunology|February 25, 2015
Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathwaysSian M Henson, Richard Macaulay, Natalie E Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2011
Reversible senescence in human CD4+CD45RA+CD27- memory T cellsDiletta Di Mitri, Rita I Azevedo, Sian M Henson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Value in Health Regional Issues|November 25, 2016
Registration and Reimbursement of New Cancer Medicines in Australia-Response to Letter to the Editor by Michael WonderRichard Macaulay
Expert Review of Pharmacoeconomics & Outcomes Research|May 13, 2021
Accounting for inflation within NICE cost-effectiveness thresholdsVincent Low, Richard Macaulay
Value in Health Regional Issues|April 27, 2018
How Data Packages Lacking Phase III Pivotal Trial Data Can Support Regulatory Approval and Reimbursement for Oncologics in AustraliaRichard Macaulay, Mohammad Kashif Siddiqui, Samuel Stoddart
Age (Dordrecht, Netherlands)|January 19, 2012
The role of the T cell in age-related inflammationRichard Macaulay, Arne N Akbar, Sian M Henson
Immunology|January 4, 2012
Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockadeSian M Henson, Richard Macaulay, Ornella Franzese, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 3, 2019
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspectiveRichard Macaulay, Amit Ahuja, Ebenezer Ademisoye, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
The Role of Noncomparative Evidence in Health Technology Assessment DecisionsElizabeth A Griffiths, Richard Macaulay, Nirma K Vadlamudi, et al.
Human Immunology|December 11, 2012
Differing HLA types influence inhibitory receptor signalling in CMV-specific CD8+ T cellsRichard Macaulay, Natalie E Riddell, Stephen J Griffiths, et al.
European Journal of Immunology|February 25, 2015
Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathwaysSian M Henson, Richard Macaulay, Natalie E Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2011
Reversible senescence in human CD4+CD45RA+CD27- memory T cellsDiletta Di Mitri, Rita I Azevedo, Sian M Henson, et al.
Pageof 2